Sharp cuts in price of cancer drugs expose excessive pricing, say health experts
NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effective from November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone…
Attributed summary
NPPA releases revised MRPs for 543 brands of anti-cancer medicines with the new prices effective from November 9; Jan Swasthya Abhiyan India (JSA India) says controlling trade margins alone is insufficient as life-saving cancer treatment must be affordable based on medical need, not a patient’s ability to pay
Read the original report — The Hindu Health
Storywire publishes attributed summaries for discoverability. Full reporting remains with the original publisher — we do not republish restricted full text.
